Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Plc Regulatory News (HAYD)

Share Price Information for Haydale Plc (HAYD)

Share Price is delayed by 15 minutes
Get Live Data
0.325    0.00 (0.00%)
Bid:
0.32
Ask:
0.33
Spread: 0.01 (3.125%)
Market Cap: £25.27m
HAYD Live PriceLast checked at - London Stock Exchange

Intraday Haydale Plc Share Chart

Grant Awards

17 Nov 2015 07:00

RNS Number : 8974F
Haydale Graphene Industries PLC
17 November 2015
 

 

Haydale Graphene Industries plc

 

("Haydale", the "Group" or the "Company")

 

Patent Grant in Australia

 

Haydale Graphene Industries plc (AIM: HAYD), the Group focused on enabling technology for the commercialisation of graphene and other nano materials, is pleased to announce receipt of the Certificate of Grant from the Patent Office of the Commonwealth of Australia. This grant relates to the key process patent underlying the Company's proprietary functionalisation treatment and is one of a number arising from the families of patent applications surrounding the Haydale plasma process.

 

Furthermore, as announced on 14 October 2015, the European Patent Office (EPO) duly granted the European patent to Haydale on 4 November 2015 and the Company has now received the Certificate of Grant from the EPO in respect of this grant.

 

Ray Gibbs, CEO at Haydale, commented:

 

"As with the earlier grant by the EPO, the patent award in Australia covers all nano particles, not just graphene, which provides Haydale with the protection to develop an extended range of nano materials. I am pleased that we now have our IP protected in China, Australia and Europe. Part of our strategy for growth is the continual development of our technology and the protection of this IP through patent applications. I look forward to being able to announce further patent awards in other territories in due course."

 

- Ends -

 

For further information, please contact:

 

Haydale Graphene Industries plc

+44 (0) 1269 842 946

John Knowles, Chairman

Ray Gibbs, Chief Executive Officer

 

Cairn Financial Advisers LLP (Nomad)

+44 (0) 20 7148 7900

Tony Rawlinson

Emma Earl

 

Cantor Fitzgerald Europe (Broker)

+44 (0) 20 7894 7000

David Foreman

David Banks

Will Goode

 

Hermes Financial PR

Trevor Phillips

Chris Steele

+44 (0) 7889 153 628

+44 (0) 7979 604 687

 

 

About Haydale

Haydale has developed a patented scalable plasma process to functionalise graphene and other nanomaterials. This enabling technology can provide Haydale with a rapid and highly cost-efficient method of supplying tailored solutions to enhance applications for both raw material suppliers and product manufacturers.

Functionalisation is carried out through a low-pressure plasma process that treats both mined, organic fine powder and other synthetically produced nanomaterial powders, producing high-quality few layered graphenes and graphene nanoplatelets. The process can functionalise with a range of chemical groups, with the level of functionalisation tailored to the customer's needs. Good dispersion improves the properties and performance of the host material and ensures the final product performs as specified.

The Haydale plasma process does not use wet chemistry, nor does it damage the material being processed; rather, it can clean up any impurities inherent in the raw material. The technology is a low energy user and most importantly environmentally friendly. The Haydale process is an enabling technology, allowing the Company to work with a raw material producer who seeks to add value to the base product and tailor the outputs to meet the target applications of the end user.

Haydale, based in South Wales and housed in a purpose-built facility for processing and handling nanomaterials, is facilitating the application of graphenes and other nanomaterials in fields such as inks, sensors, energy storage, photovoltaics, composites, paints and coatings.

www.haydale.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPKADKABDDFDD
Date   Source Headline
11th Jan 20222:14 pmRNSResult of AGM
11th Jan 20227:00 amRNSGNPs Enhance Clothing for iCraft and Pro-Specs
10th Jan 20227:00 amRNSChange of Adviser
24th Dec 202112:41 pmRNSSecond Price Monitoring Extn
24th Dec 202112:35 pmRNSPrice Monitoring Extension
17th Dec 20217:00 amRNSPosting of Annual Report and Notice of AGM
15th Dec 20217:16 amRNSFinal Results
10th Dec 20214:41 pmRNSSecond Price Monitoring Extn
10th Dec 20214:36 pmRNSPrice Monitoring Extension
10th Dec 20212:06 pmRNSSecond Price Monitoring Extn
10th Dec 20212:00 pmRNSPrice Monitoring Extension
5th Nov 20217:00 amRNSDate of Results
26th Oct 20219:05 amRNSSecond Price Monitoring Extn
26th Oct 20219:00 amRNSPrice Monitoring Extension
18th Oct 20217:00 amRNSNotice of Results
20th Sep 202111:49 amRNSResult of Oversubscribed Fundraising
20th Sep 20217:01 amRNSPrimaryBid Offer
20th Sep 20217:00 amRNSProposed Placing and Subscription
1st Sep 20217:00 amRNSUS Small Business Administration Loan Agreement
19th Aug 20217:00 amRNSHigh Performance Garments – Used in Tokyo
16th Aug 20217:51 amRNSFiling of Joint Patent with Airbus
2nd Aug 20217:00 amRNSIssue of Warrants
12th Jul 20217:00 amRNSCollaboration agreement with ProMake Limited
28th May 20212:05 pmRNSSecond Price Monitoring Extn
28th May 20212:01 pmRNSPrice Monitoring Extension
26th Apr 20217:00 amRNSExtension to CeramycGuard Distributor Agreement
6th Apr 20217:00 amRNSFeasibility Study Award
29th Mar 20217:00 amRNS401 Tech Bridge Partners with Haydale
26th Mar 202111:11 amRNS£1.1 million Innovate UK Loan Agreement
25th Mar 20212:00 pmRNSPrice Monitoring Extension
1st Mar 20217:00 amRNSBiwater Trial CeramycShield™ Treatment
26th Feb 20214:40 pmRNSSecond Price Monitoring Extn
26th Feb 20214:35 pmRNSPrice Monitoring Extension
24th Feb 20217:00 amRNSInterim Results
9th Feb 20217:00 amRNSFunctionalised Masterbatch Used in Bolflex Sole
5th Feb 20214:41 pmRNSSecond Price Monitoring Extn
5th Feb 20214:35 pmRNSPrice Monitoring Extension
28th Jan 20217:00 amRNSSales Representation Agreement and Trading Update
18th Jan 20219:00 amRNSPrice Monitoring Extension
30th Dec 20204:41 pmRNSSecond Price Monitoring Extn
30th Dec 20204:35 pmRNSPrice Monitoring Extension
15th Dec 20209:05 amRNSSecond Price Monitoring Extn
15th Dec 20209:00 amRNSPrice Monitoring Extension
8th Dec 202012:09 pmRNSResult of AGM
7th Dec 202012:30 pmRNSDistributor Agreement for iCraft PPE Mask
27th Nov 20207:00 amRNSFunctionalised Graphene Antibacterial Masks
18th Nov 20204:40 pmRNSSecond Price Monitoring Extn
18th Nov 20204:35 pmRNSPrice Monitoring Extension
10th Nov 20207:00 amRNSNotice of Annual General Meeting
30th Oct 20207:00 amRNSFull Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.